IL6 and hepatocellular carcinoma: Besides, patients with high predicted risk metastasis signature also displayed higher IL-6 expression than patients with low predicted risk metastasis signature, which indicated the oncogenic role of IL-6 in inflammation-associated HCC (Supplementary Fig. S1B).